|
1
|
Wagle NS, Nogueira L, Devasia TP, Devasia
TP, Mariotto AB, Yabroff KR, Islami F, Jemal A, Alteri R, Ganz PA
and Siegel RL: Cancer treatment and survivorship statistics, 2025.
CA Cancer J Clin. 75:308–340. 2025.PubMed/NCBI
|
|
2
|
Choi E, Hua Y, Su CC, Wu JT, Neal JW,
Leung AN, Backhus LM, Haiman C, Le Marchand L, Liang SY, et al:
Racial and ethnic differences in second primary lung cancer risk
among lung cancer survivors. JNCI Cancer Spectr. 8:pkae0722024.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Freire MV, Thissen R, Martin M, Fasquelle
C, Helou L, Durkin K, Artesi M, Lumaka A, Leroi N, Segers K, et al:
Genetic evaluation of patients with multiple primary cancers. Oncol
Lett. 29:42024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanjak P, Suktitipat B, Vorasan N,
Juengwiwattanakitti P, Thiengtrong B, Songjang C, Therasakvichya S,
Laiteerapong S and Chinswangwatanakul V: Risks and cancer
associations of metachronous and synchronous multiple primary
cancers: A 25-year retrospective study. BMC Cancer. 21:10452021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ge S, Wang B, Wang Z, He J and Ma X:
Common multiple primary cancers associated with breast and
gynecologic cancers and their risk factors, pathogenesis, treatment
and prognosis: A review. Front Oncol. 12:8404312022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang BX, Brantley KD, Rosenberg SM,
Kirkner GJ, Collins LC, Ruddy KJ, Tamimi RM, Schapira L, Borges VF,
Warner E, et al: Second primary non-breast cancers in young breast
cancer survivors. Breast Cancer Res Treat. 207:587–597. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trapani JA, Thia KY, Andrews M, Davis ID,
Gedye C, Parente P, Svobodova S, Chia J, Browne K, Campbell IG, et
al: Human perforin mutations and susceptibility to multiple primary
cancers. OncoImmunology. 2:e241852013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aredo JV, Luo SJ, Gardner RM, Sanyal N,
Choi E, Hickey TP, Riley TL, Huang WY, Kurian AW, Leung AN, et al:
Tobacco smoking and risk of second primary lung cancer. J Thorac
Oncol. 16:968–979. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Vries S, Schaapveld M, Janus CPM,
Daniëls LA, Petersen EJ, van der Maazen RWM, Zijlstra JM, Beijert
M, Nijziel MR, Verschueren KMS, et al: Long-term cause-specific
mortality in hodgkin lymphoma patients. J Natl Cancer Inst.
113:760–769. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou B, Zang R, Song P, Zhang M, Bie F,
Bai G, Li Y, Huai Q, Han Y and Gao S: Association between
radiotherapy and risk of second primary malignancies in patients
with resectable lung cancer: A population-based study. J Transl
Med. 21:102023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Division of Cancer Control and Population
Sciences Program Areas, . Long Term Survivorship. Definitions.
National Cancer Institute; 2020
|
|
12
|
Tian M, Shen J, Liu M, Chen XF, Wang TJ
and Sun YS: Prognostic factors and nomogram development for
survival in renal cell carcinoma patients with multiple primary
cancers: A retrospective study. Transl Androl Urol. 14:685–695.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun
Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
15
|
Wu T, Miao W, Qukuerhan A, Alimu N, Feng
J, Wang C, Zhang H, Du H and Chen L: Global, regional, and national
burden of nasopharyngeal carcinoma from 1990 to 2021. Laryngoscope.
135:1409–1418. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang LL, Li GH, Li YY, Qi ZY, Lin AH and
Sun Y: Risk assessment of secondary primary malignancies in
nasopharyngeal carcinoma: A big-data intelligence platform-based
analysis of 6,377 long-term survivors from an endemic area treated
with intensity-modulated radiation therapy during 2003–2013. Cancer
Res Treat. 51:982–991. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chow JCH, Au KH, Mang OWK, Cheung KM and
Ngan RKC: Risk, pattern and survival impact of second primary
tumors in patients with nasopharyngeal carcinoma following
definitive intensity-modulated radiotherapy. Asia Pac J Clin Oncol.
15:48–55. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Svärd F, Alabi RO, Leivo I, Mäkitie AA and
Almangush A: The risk of second primary cancer after nasopharyngeal
cancer: A systematic review. Eur Arch Otorhinolaryngol.
280:4775–4781. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao C, Miao JJ, Hua YJ, Wang L, Han F, Lu
LX, Xiao WW, Wu HJ, Zhu MY, Huang SM, et al: Locoregional control
and mild late toxicity after reducing target volumes and radiation
doses in patients with locoregionally advanced nasopharyngeal
carcinoma treated with induction chemotherapy (IC) followed by
concurrent chemoradiotherapy: 10-year results of a phase 2 study.
Int J Radiat Oncol Biol Phys. 104:836–844. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scélo G, Boffetta P, Corbex M, Chia KS,
Hemminki K, Friis S, Pukkala E, Weiderpass E, McBride ML, Tracey E,
et al: Second primary cancers in patients with nasopharyngeal
carcinoma: A pooled analysis of 13 cancer registries. Cancer Causes
Control. 18:269–278. 2007.PubMed/NCBI
|
|
21
|
Guzzinati S, Buja A, Grotto G, Zorzi M,
Manfredi M, Bovo E, Del Fiore P, Tropea S, Dall'Olmo L, Rossi CR,
et al: Synchronous and metachronous multiple primary cancers in
melanoma survivors: A gender perspective. Front Public Health.
11:11954582023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Jiang Y, Bai Y and Xu H: Do cancer
survivors have an increased risk of developing subsequent cancer? A
population-based study. J Transl Med. 23:3552025. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bugter O, Van Iwaarden DLP, Dronkers EAC,
de Herdt MJ, Wieringa MH, Verduijn GM, Mureau MAM, Ten Hove I, van
Meerten E, Hardillo JA and Baatenburg de Jong RJ: Survival of
patients with head and neck cancer with metachronous multiple
primary tumors is surprisingly favorable. Head Neck. 41:1648–1655.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang X, Zhang C, Zhou H, Zhang J, Yan W,
Zhong WZ and Chen KN: Multiple pulmonary resections for synchronous
and metachronous lung cancer at two Chinese centers. Ann Thorac
Surg. 109:856–863. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fan H, Wen R, Zhou L, Gao X, Lou Z, Hao L,
Meng R, Gong H, Yu G and Zhang W: Clinicopathological features and
prognosis of synchronous and metachronous colorectal cancer: A
retrospective cohort study. Int J Surg. 109:4073–4090. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tamura K, Fujimoto T, Shimizu T, Nagayoshi
K, Mizuuchi Y, Hisano K, Horioka K, Shindo K, Nakata K, Ohuchida K
and Nakamura M: Clinical features, surgical treatment strategy, and
feasibility of minimally invasive surgery for synchronous and
metachronous multiple colorectal cancers: A 14-year single-center
experience. Surg Endosc. 38:7139–7151. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
World Health Organization (WHO), .
International Statistical Classification of Diseases and Related
Health Problems. 10th Revision (ICD-10). WHO; Geneva: 2016,
https://icd.who.int/browse10/2016/en#/C11
|
|
28
|
Warren S and Gates O: Multiple primary
malignant tumors: A survey of the literature and a statistical
study. Am J Cancer. 16:1358–1414. 1932.
|
|
29
|
Working Group Report: International rules
for multiple primary cancers (ICD-0 third edition). Eur J Cancer
Prev. 14:307–308. 2005. View Article : Google Scholar
|
|
30
|
Yang XB, Zhang LH, Xue JN, Wang YC, Yang
X, Zhang N, Liu D, Wang YY, Xun ZY, Li YR, et al: High incidence
combination of multiple primary malignant tumors of the digestive
system. World J Gastroenterol. 28:5982–5992. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo LF, Hong JG, Wang RJ, Chen GP and Wu
SG: Nasopharyngeal carcinoma survival by histology in endemic and
non-endemic areas. Ann Med. 56:24250662024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Duncan MS, Freiberg MS, Greevy RA Jr,
Kundu S, Vasan RS and Tindle HA: Association of smoking cessation
with subsequent risk of cardiovascular disease. JAMA. 322:642–650.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho JH, Shin SY, Kim H, Kim M, Byeon K,
Jung M, Kang KW, Lee WS, Kim SW and Lip GYH: Smoking cessation and
incident cardiovascular disease. JAMA Netw Open. 7:e24426392024.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lydiatt WM, Patel SG, O'Sullivan B,
Brandwein MS, Ridge JA, Migliacci JC, Loomis AM and Shah JP: Head
and neck cancers-major changes in the American joint committee on
cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:122–137. 2017.PubMed/NCBI
|
|
35
|
Adelstein D, Gillison ML, Pfister DG,
Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ,
Cmelak AJ, et al: NCCN guidelines insights: Head and neck cancers,
version 2.2017. J Natl Compr Canc Netw. 15:761–770. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li F, Zhong WZ, Niu FY, Zhao N, Yang JJ,
Yan HH and Wu YL: Multiple primary malignancies involving lung
cancer. BMC Cancer. 15:6962015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ventura L, Carbognani P, Gnetti L, Rossi
M, Tiseo M, Silini EM, Sverzellati N, Silva M, Succi M, Braggio C,
et al: Multiple primary malignancies involving lung cancer: A
single-center experience. Tumori. 107:196–203. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wynder EL, Mushinski MH and Spivak JC:
Tobacco and alcohol consumption in relation to the development of
multiple primary cancers. Cancer. 40 (4 Suppl):S1872–S1878. 1977.
View Article : Google Scholar
|
|
39
|
Oeffinger KC, Baxi SS, Novetsky Friedman D
and Moskowitz CS: Solid tumor second primary neoplasms: Who is at
risk, what can we do? Semin Oncol. 40:676–689. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hung RJ, Baragatti M, Thomas D, McKay J,
Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova
E, Mates D, et al: Inherited predisposition of lung cancer: A
hierarchical modeling approach to DNA repair and cell cycle control
pathways. Cancer Epidemiol Biomarkers Prev. 16:2736–2744. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Amer M: Multiple neoplasms, single
primaries, and patient survival. Cancer Manag Res. 6:119–134. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liberale C, Soloperto D, Marchioni A,
Monzani D and Sacchetto L: Updates on larynx cancer: Risk factors
and oncogenesis. Int J Mol Sci. 24:129132023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Goggins WB, Yu IT, Tse LA, Leung SF, Tung
SY and Yu KS: Risk of second primary malignancies following
nasopharyngeal carcinoma in Hong Kong. Cancer Causes Control.
21:1461–1466. 2010.PubMed/NCBI
|
|
44
|
Slaughter DP, Southwick HW and Smejkal W:
Field cancerization in oral stratified squamous epithelium.
Clinical implications of multicentric origin. Cancer. 6:963–968.
1953. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hayat MJ, Howlader N, Reichman ME and
Edwards BK: Cancer statistics, trends, and multiple primary cancer
analyses from the surveillance, epidemiology, and end results
(SEER) program. Oncologist. 12:20–37. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Watanabe S, Kodama T, Shimosato Y, Arimoto
H, Sugimura T, Suemasu K and Shiraishi M: Multiple primary cancers
in 5,456 autopsy cases in the National cancer center of Japan. J
Natl Cancer Inst. 72:1021–1027. 1984.PubMed/NCBI
|
|
47
|
Boucai L, Zafereo M and Cabanillas ME:
Thyroid cancer: A review. JAMA. 331:425–435. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang X, Wang Z, Chen Y, Lin Q, Chen H, Lin
Y, Lu L, Zheng P and Chen X: Impact of prior cancer on the overall
survival of patients with nasopharyngeal carcinoma. Am J
Otolaryngol. 43:1032352022. View Article : Google Scholar : PubMed/NCBI
|
